News? Good or bad?11:23 AM EST, 12/21/2018 (MT Newswires) -- Therapix Biosciences (TRPX) has terminated its proposed merger with FSD Pharma after material terms in the letter of intent (LOI) were modified by FSD Pharma. As a result of these modifications, Therapix said it does not believe it will come to an agreement on the revised terms. Therapix did not specify what modifications were made to the LOI that led to the merger termination. Price: 3.78, Change: -0.76, Percent Change: -16.74